Alzheimer’s
10 May 2016 - 11 May 2016
SMi is thrilled to introduce Alzheimer's 2016! As more and more people live longer and the population ages, Alzheimer's has been identified as one of the biggest health problems in the 21st century. In the UK alone, a new report by the HSCIC has indicated that the number of patients being prescribed with drugs to treat Alzheimer’s has risen six-fold in the last 10 years. A 5 year strategy to fight dementia unveiled by the UK Government last year, reflects greater efforts to tackle the disease in the UK. Alzheimer’s 2016 will hone in on early intervention strategies as well as solutions to on-going drug development challenges. It will strengthen knowledge in key topics such as; tau aggression; risk profiling; investment options; regulations, MRI imaging and biomarker evaluation, whilst looking at the practicalities of meaningful data from trials and keeping attendees at the forefront of clinical breakthroughs to adapt to the growing need for new treatments. Understanding behavioural and psychiatric symptoms will be a major focus, as will hearing from a selection of pharmaceutical companies currently modelling disease progression. An exclusive update on funding opportunities and academic drug discovery from Alzheimer’s Research UK, will be just one of the event highlights for 2016. Other speakers include: Janssen, GSK, Merck, Eli Lilly, plus many more! For further details and to register, visit http://www.alzheimers-conference.com/ddt
Holiday Inn Kensington Forum, London, UK
http://www.alzheimers-conference.com/ddt
10th Drug Design & Medicinal Chemistry Conference
11 May 2016 - 12 May 2016
We are excited to announce the 10th Drug Design & Medicinal Chemistry Conference, to be held May 11-12, 2016 in Berlin, Germany. This meeting will provide a multi-disciplinary forum for industry and academia colleagues to gather and explore the changing landscape of drug discovery in emerging target classes and chemical biology approaches for discovering new medicines. Leaders in the field will present on hot topics such as protein-protein interactions, overcoming resistance in drug design, allosteric inhibitors, and many more. Attendees will also have the opportunity to meet colleagues during dedicated networking sessions and form new connections.
Maritim Hotel Berlin, Berlin, Germany
https://www.gtcbio.com/conferences/drug-design-medicinal-chemistry-overview
2nd Kinase Inhibitors Design & Screening Conference
12 May 2016 - 13 May 2016
GTCbio and the Advisory Board would like to invite you the 2nd Kinase Inhibitors Design & Screening Conference. This event takes place May 12-13, 2016 in Berlin, Germany. The conference brings together industry leaders from major pharmaceuticals, biotech companies, and top researchers from academia to provide a timely and critical update on significant kinase inhibitors and to better understand current trends for drug design and screening processes. This meeting’s discussion and presentations will circle around recent developments in allosteric kinase inhibitors, covalent inhibitor strategies, irreversible and RAF inhibitors, mechanisms of kinase inhibitor resistance, and mutation-focused approaches towards kinase inhibition.
Maritim Hotel Berlin, Berlin, Germany
https://www.gtcbio.com/conferences/kinase-inhibitors-design-screening-overview
Advances in Immuno-oncology Congress 2016
12 May 2016 - 13 May 2016
Discovering new ways to effectively target and treat cancer is one of the most pressing challenges for the pharmaceutical industry today. The field of immuno-oncology is currently predicted to reach a value totalling $25 billion annually by 2020. At this crucial time of growth and advancement, this congress offers invaluable insights into key technological and scientific innovations. Addressing the main challenges and opportunities in the industry, delegates will learn more about hot areas including the discovery of novel viral, antibody and cell-based therapies, clinical partnerships and approaches to combination therapies.
tbc London, UK
http://www.immunooncology-congress.com/?dm_i=1URA,3Y5CJ,LC13QR,E8ST2,1
10th Annual Clinical Trial Logistics
18 May 2016 - 19 May 2016
SMi’s 10th annual Clinical Trial Logistics event will bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs, learn about the logistical challenges in emerging markets and examine the latest innovations made on maintaining temperature in shipment.
Holiday Inn Kensington Forum, London, UK
http://www.clinical-trial-logistics.com/ddt
ADC Summit
23 May 2016 - 24 May 2016
With the FDA's recent approval of ADCs Adcetris and Kadcyla, the industry has never been moving faster. New innovations in developing the next best generation ADCs are bursting into the clinic at a rapid rate.
SMi's 5th annual ADC Summit provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more.
Join industry experts as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success. Early bird discount of £400 for bookings before 29 February.
Holiday Inn Kensington Forum, London, UK
http://www.adcsummit.com/ddt
Pain Therapeutics
23 May 2016 - 24 May 2016
SMi’s 16th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research. Aimed at an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2016 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery. Presentations from a selection of leading pharmaceutical companies currently developing novel analgesic treatments including Glenmark, Pfizer, GSK, Grunenthal and Nektar Pharmaceuticals, will provide delegates with an understanding on key topics such as drug development mechanisms, neuropathic pain, severe chronic pain, sodium channels, industry challenges, plus much more! An interactive panel discussion on medical incidents in experimental clinical trials will be just one of the highlights at the conference this spring. For further details and to register, visit http://www.pain-therapeutics.co.uk/ddt
Holiday Inn Kensington Forum, London, UK
http://www.pain-therapeutics.co.uk/ddt